Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus propofol vs saline plus propofol for outpatient colonoscopy recovery
ChiCTR2200065532Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Intestinal disease (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Proportion of patients ready for discharge within postoperative 30 minutes. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Intestinal disease
Beyond the preview
Go deeper on ChiCTR2200065532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065532.